Mayer’s practice focuses on general commercial law with a speciality in capital raising, financing transactions, mergers and acquisitions.
Mayer provides ongoing commercial advice to international corporations, public and private companies, local and international partnerships, and various projects.
Mayer represents high-tech companies from their initial stages through to their growth, issuances, or sales. In this context, Mayer provides legal services to high-tech and technology companies regarding all aspects of their ongoing activities, and advices them in different transactions, including various commercial agreements, technology agreements, intellectual property issues, joint development agreements, production agreements, technology purchase agreements, and more.
In addition, Mayer has extensive experience in banking and finance which allows him to tailor build the proper financing combinations for his clients.
Mayer’s clients include international companies and foreign investors, local venture capital funds, banks, and various funding bodies.
Mayer joined Barnea in 2014
Bar Ilan University (LL.B), 2010
Member of Israel Bar Association since 2012
News and updates - Mayer Winkler:
Barnea & Co. represented Johnson & Johnson regarding its investment in the startup, DayTwo
Barnea & Co. represented Johnson & Johnson in respect of its investment of USD 12 million in the startup, DayTwo, which provides personalized nutrition recommendations based on mapping and analyzing the composition of intestinal bacteria.
Barnea & Co. Represented the Private Equity Fund IGP Investment in Jacada
Barnea & Co. represented Israel Growth Partners (IGP) in an agreement to buy 300,000 Jacada shares, 7% of the company's share capital, from Robert (Bob) Ashton's investment firm Kinetic Catalyst Partners.
Barnea & Co. advises Johnson & Johnson regarding its participation in a $28m investment round carried out by Israel's V-Wave
V-Wave, a privately held company with offices in Israel and the U.S., completed a Series B financing round in the sum of $28m.
The round was led by Johnson & Johnson Innovation - JJDC Inc. (represented by Barnea & Co.). Other participants were TriVentures, Pura Vida and BioStar Ventures. Eli and Nir Barkat's BRM fund, Pontifax and Edwards Lifesciences, which were already shareholders in V-Wave, also participated.